Description
MOTS-C Peptide – Research Grade Compound
MOTS-C is a mitochondrial-derived peptide that has gained attention in scientific research for its potential role in cellular metabolism and mitochondrial signaling pathways. Researchers study MOTS-C to better understand how mitochondrial peptides interact with cellular processes and metabolic regulation.
Our MOTS-C peptide USA product is supplied in high-purity lyophilized powder form, making it suitable for controlled laboratory experiments and peptide analysis.
This compound is designed for professional research laboratories that require reliable and consistent peptide materials.
Product Features
- High-purity MOTS-C research peptide
- Lyophilized powder for improved stability
- Laboratory-grade quality
- Sterile sealed vial packaging
- Fast and secure shipping within the USA
Research Applications
In scientific settings, MOTS-C peptides are commonly explored in studies involving:
- Mitochondrial peptide signaling
- Cellular metabolism research
- Molecular and biochemical pathways
- Peptide interaction and stability studies
These investigations are typically performed in controlled laboratory environments by qualified researchers.
Quality Assurance
Every batch of MOTS-C peptide is produced under strict quality control standards and tested to ensure:
- High peptide purity
- Reliable structural consistency
- Reproducible laboratory results
Certificates of Analysis (COA) may be available upon request.
Storage Information
For optimal stability, store MOTS-C peptide in a cool, dry environment and follow proper laboratory handling procedures after reconstitution.
Shipping Information
- Secure and discreet packaging
- Professional handling of research materials
- Fast delivery throughout the USA
Disclaimer
This product is intended strictly for laboratory research purposes only. It is intended for human or veterinary use. By purchasing this product, the buyer confirms that it will only be used in qualified research environments.









Reviews
There are no reviews yet.